TABLE 3.
Odds Ratio (95% CI); P value | Odds Ratio (95% CI); P value * | |
LMNA variant compared to non-LMNA | ||
Arrhythmia | 2.93 (1.29–6.64); 0.010 | 3.77 (1.45–9.83); 0.007 |
Atrial fibrillation/ Atrial flutter | 5.30 (1.11–25.39); 0.037 | 5.78 (1.04–32.16); 0.045 |
Conduction abnormality | 1.90 (0.70–5.17); 0.211 | 2.20 (0.71–6.85); 0.173 |
Odds Ratio (95% CI); p value | Odds Ratio (95% CI); P value † | |
Non-482 LMNA variant compared to 482 | ||
Arrhythmia | 3.37 (1.12–10.08); 0.030 | 4.74 (1.41–15.98); 0.012 |
Atrial fibrillation/ Atrial flutter | 5.44 (1.24–23.95); 0.025 | 17.67 (2.45–127.68); 0.004 |
Conduction abnormality | 3.77 (1.05–13.57); 0.042 | 5.71 (1.37–23.76); 0.017 |
Adjusted for age at cardiac examination, BMI, comorbidities. Sex distribution and diabetes were not included in the model since >85% are diabetics and >80% are females. In addition, sex distribution was not different between LMNA and non-LMNA group, and the sample size did not allow for extra parameters in the model. Seven patients with no complete gene sequencing for LMNA are excluded.
Adjusted only for age at cardiac examination due to limited sample size. Seven patients with no complete gene sequencing for LMNA are excluded.